Author/Creator: Gonzalez-Rivera, Tania - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Gonzalez-Rivera, Tania

1. 10 Years of belimumab experience: What have we learnt?. (October 2021)

Authors:: Levy, Roger A; Gonzalez-Rivera, Tania; Khamashta, Munther; Fox, Norma Lynn; Jones-Leone, Angela; Rubin, Bernie; Burriss, Susan W; Gairy, Kerry; Maurik, Andre van; Roth, David A
Journal:: Lupus
Issue:: Volume 30:Number 11(2021)
Page Start:: 1705
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 1104 Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) With Relapsed and Newly Diagnosed Active Lupus Nephritis (LN). (14th December 2022)

Authors:: Anders, Hans-Joachim; Rovin, Brad H; Zhao, Ming-Hui; Malvar, Ana; Hiromura, Keiju; Leone, Angela Jones-; Gonzalez-Rivera, Tania; Gilbride, Jennifer; Madan, Anuradha; Green, Yulia; Roth, David A
Journal:: Lupus science & medicine
Issue:: Volume 9(2022)Supplement 3
Page Start:: A70
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. FC 034SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS: A 6-MONTH OPEN-LABEL EXTENSION. (29th May 2021)

Authors:: Rovin, Brad; Furie, Richard; Houssiau, Frédéric A; Contreras, Gabriel; Teng, Y K O; Curtis, Paula; Madan, Anuradha; Jones-leone, Angela; Gonzalez-Rivera, Tania; Okily, Mohamed; Roth, David
Journal:: Nephrology dialysis transplantation
Issue:: Volume 36(2021)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Pembrolizumab-associated inflammatory myopathy. (23rd October 2017)

Authors:: Gandiga, Prateek C; Wang, Amber R; Gonzalez-Rivera, Tania; Sreih, Antoine G
Journal:: Rheumatology
Issue:: Volume 57:Number 2(2018)
Page Start:: 397
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?. Issue 3 (May 2015)

Authors:: McCune, W. Joseph; Gonzalez-Rivera, Tania
Journal:: Current opinion in rheumatology
Issue:: Volume 27:Issue 3(2015:May)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?. Issue 3 (May 2015)

Authors:: McCune, W. Joseph; Gonzalez-Rivera, Tania
Journal:: Current opinion in rheumatology
Issue:: Volume 27:Issue 3(2015:May)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗